Smith & Nephew Plc Directorate Change (6682Y)
04 Gennaio 2024 - 11:02AM
UK Regulatory
TIDMSN.
RNS Number : 6682Y
Smith & Nephew Plc
04 January 2024
4 January 2024
Board change
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology
business , announces that following completion of his nine-year
tenure, Erik Engstrom stepped down from the Board on 31 December
2023.
The Board would like to thank Erik for his commitment and
contribution to the Board and the Company.
Enquiries
Investors / Analysts
Andrew Swift
Smith+Nephew +44 (0) 1923 477433
Media
Charles Reynolds
Smith+Nephew +44 (0) 1923 477314
Susan Gilchrist / Ayesha Bharmal
Brunswick +44 (0) 20 7404 5959
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business that
exists to restore people's bodies and their self-belief by using
technology to take the limits off living. We call this purpose
'Life Unlimited'. Our 19,000 employees deliver this mission every
day, making a difference to patients' lives through the excellence
of our product portfolio, and the invention and application of new
technologies across our three global business units of
Orthopaedics, Advanced Wound Management and Sports Medicine &
ENT.
Founded in Hull, UK, in 1856, we now operate in more than 100
countries, and generated annual sales of $5.2 billion in 2022.
Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN).
The terms 'Group' and 'Smith+Nephew' are used to refer to Smith
& Nephew plc and its consolidated subsidiaries, unless the
context requires otherwise.
For more information about Smith+Nephew, please visit
www.smith-nephew.com and follow us on X , LinkedIn , Instagram or
Facebook .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOABGGDBGGGDGSS
(END) Dow Jones Newswires
January 04, 2024 05:02 ET (10:02 GMT)
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Mag 2023 a Mag 2024